New opioid aims to ease pain without slowing digestion
NCT ID NCT07307495
First seen Jan 04, 2026 · Last updated May 12, 2026 · Updated 18 times
Summary
This study tests a new pain medicine, oliceridine fumarate, in 428 adults having lumbar spine surgery. The goal is to see if it controls pain as well as standard opioids but helps the gut recover faster (eating solid food and passing gas). Participants will be randomly assigned to receive oliceridine or a placebo after surgery, and their recovery will be tracked for 48 hours.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OLICERIDINE FUMARATE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.